跳转至内容
Merck
CN
  • Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.

Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.

Journal of enzyme inhibition and medicinal chemistry (2010-12-31)
Ghassan Abu Sheikha, Mahmoud A Al-Sha'er, Mutasem O Taha
摘要

Eight selected sulfonamide drugs were investigated as inhibitors of heat shock protein 90 (Hsp90). The investigation included simulated docking experiments to fit the selected compounds within the binding pocket of Hsp90. The selected molecules were found to readily fit within the ATP-binding pocket of Hsp90 in low-energy poses. The sulfonamides torsemide, sulfathiazole, and sulfadiazine were found to inhibit the ATPase activity of Hsp90 with IC(50) values of 1.0, 2.6, and 1.5 μM, respectively. Our results suggest that these well-established sulfonamides can be good leads for subsequent optimization into potent Hsp90 inhibitors.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
磺胺胍
Supelco
磺胺胍, VETRANAL®, analytical standard